Apricus Biosciences Inc is a hybrid specialty pharmaceutical company in the areas of oncology sexual dysfunction autoimmune and anti-infectives among others.


Updates from The Motley Fool

Latest updates on Apricus Biosciences from Fool.com.


Stock Performance

View Interactive APRI Charts
Sponsored by

Key Data Points

Primary metrics and data points about Apricus Biosciences.
Current Price: $2.21
Prev Close: $2.21
Open: $2.14
Bid: $1.90
Ask: $2.24
Day's Range: $2.12 - $2.24
52wk Range: $1.10 - $7.15
Volume: 35,119
Avg Vol 349,302
Market Cap: $17M
P/E (ttm): -1.88
EPS (ttm): ($1.14)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Apricus Biosciences.
CAPS Rating 1 out of 5
 
59 Outperform
20 Underperform
CAPS All Stars
 
4 Outperform
11 Underperform

How do you think Apricus Biosciences will perform against the market?



You pick for Apricus Biosciences is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Bassam B. Damaj, CEO

100% Approve

Based on 1 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Apricus Biosciences.

Apricus Biosciences Inc is a hybrid specialty pharmaceutical company in the areas of oncology sexual dysfunction autoimmune and anti-infectives among others.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers